SGMO icon

Sangamo Therapeutics

134 hedge funds and large institutions have $61.3M invested in Sangamo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

55% less capital invested

Capital invested by funds: $137M → $61.3M (-$76M)

65% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 26

Holders
134
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$91K
Puts
$81K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.8M
2
$9.48M
3
$7.52M
4
$3.94M
5
$2.72M
6
$2.22M
7
$1.8M
8
$1.75M
9
$1.61M
10
$1.5M
11
$1.42M
12
$1.13M
13
$975K
14
$843K
15
$823K
16
$779K
17
$740K
18
$714K
19
$714K
20
$608K
21
$542K
22
$538K
23
$506K
24
$482K
25
$458K